Open AccessThis article is
- freely available
Encapsulation of Hydrocortisone and Mesalazine in Zein Microparticles
School of Pharmacy, the University of Queensland, Brisbane, QLD 4072, Australia
Department of Pharmacy, King's College London, London SE1 8WA, UK
Food Science and Technology Program, Curtin Health Innovation Research Institute, Curtin University, Perth, WA 6102, Australia
Centre for Nutrition and Food Sciences, Queensland Alliance for Agriculture and Food Innovation, The University of Queensland, Brisbane, QLD 4072, Australia
Australian Institute for Bioengineering and Nanotechnology, and School of Chemical Engineering, The University of Queensland, Brisbane, QLD 4072, Australia
* Author to whom correspondence should be addressed.
Received: 4 February 2013; in revised form: 29 April 2013 / Accepted: 3 May 2013 / Published: 10 May 2013
(This article belongs to the Special Issue Prodrugs
Abstract: Zein was investigated for use as an oral-drug delivery system by loading prednisolone into zein microparticles using coacervation. To investigate the adaptability of this method to other drugs, zein microparticles were loaded with hydrocortisone, which is structurally related to prednisolone; or mesalazine, which is structurally different having a smaller LogP and ionizable functional groups. Investigations into the in vitro digestibility, and the electrophoretic profile of zein, and zein microparticles were conducted to shed further insight on using this protein as a drug delivery system. Hydrocortisone loading into zein microparticles was comparable with that reported for prednisolone, but mesalazine loading was highly variable. Depending on the starting quantities of hydrocortisone and zein, the average amount of microparticles equivalent to 4 mg hydrocortisone, (a clinically used dose), ranged from 60–115 mg, which is realistic and practical for oral dosing. Comparatively, an average of 2.5 g of microparticles was required to deliver 250 mg of mesalazine (a clinically used dose), so alternate encapsulation methods that can produce higher and more precise mesalazine loading are required. In vitro protein digestibility revealed that zein microparticles were more resistant to digestion compared to the zein raw material, and that individual zein peptides are not preferentially coacervated into the microparticles. In combination, these results suggest that there is potential to formulate a delivery system based on zein microparticles made using specific subunits of zein that is more resistant to digestion as starting material, to deliver drugs to the lower gastrointestinal tract.
Keywords: maize; microparticles; protein; drug loading; in vitro digestibility; electrophoresis
Citations to this Article
Cite This Article
MDPI and ACS Style
Lau, E.T.L.; Giddings, S.J.; Mohammed, S.G.; Dubois, P.; Johnson, S.K.; Stanley, R.A.; Halley, P.J.; Steadman, K.J. Encapsulation of Hydrocortisone and Mesalazine in Zein Microparticles. Pharmaceutics 2013, 5, 277-293.
Lau ETL, Giddings SJ, Mohammed SG, Dubois P, Johnson SK, Stanley RA, Halley PJ, Steadman KJ. Encapsulation of Hydrocortisone and Mesalazine in Zein Microparticles. Pharmaceutics. 2013; 5(2):277-293.
Lau, Esther T.L.; Giddings, Steven J.; Mohammed, Salmaan G.; Dubois, Paul; Johnson, Stuart K.; Stanley, Roger A.; Halley, Peter J.; Steadman, Kathryn J. 2013. "Encapsulation of Hydrocortisone and Mesalazine in Zein Microparticles." Pharmaceutics 5, no. 2: 277-293.